CME Group FX Futures Reach New Volume and Open Interest Records

Published

CHICAGO, Dec. 13, 2019 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, announced its foreign exchange (FX) futures reached a new single-day volume record of 2.7 million contracts on Dec. 11, 2019, surpassing the previous record of 2.5 million contracts set on June 14, 2017.

Open interest (OI) for CME Group FX futures also reached a record 2.3 million contracts on Dec. 11, 2019, up from the previous OI record of 2.2 million contracts set on Dec. 10, 2019.

OI represents the number of active positions that market participants are holding open without taking delivery or offsetting, a measure that typically increases during times of market uncertainty.

"Customers are increasingly accessing the deep liquidity, as well as capital and cost efficiencies, offered by our listed FX products to manage their FX exposure," said Paul Houston, CME Group Global Head of FX. "Record open interest, combined with our recent reductions in minimum price increments for calendar spreads in euro, yen and pound pairs, has continued to strengthen liquidity and reduce the cost to trade during this year-end roll period."

Individually, Mexican Peso (230,897 contracts) and Norwegian Krona (2,340 contracts) also reached single-day trading volume records on Dec. 10, 2019.

Large open interest holders (LOIHs) in FX futures reached a record high of 1,261, up 18 percent to date in 2019 compared to the previous year. LOIHs are a measure of market diversification.

For more than 45 years, CME Group has offered unparalleled liquidity and access to listed FX markets for customers around the clock and around the world. CME Group offers the widest range of global benchmark products across all major asset classes, helping businesses everywhere mitigate the complex risks they face in today's uncertain global economy.

FX futures are listed on and subject to the rules of CME. For more information about CME Group FX products, please visit cmegroup.com/fx.

As the world's leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest ratesequity indexesforeign exchangeenergyagricultural products and metals.  The company offers futures and options on futures trading through the CME Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. With a range of pre- and post-trade products and services underpinning the entire lifecycle of a trade, CME Group also offers optimization and reconciliation services through TriOptima, and trade processing services through Traiana.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec, EBS, TriOptima, and Traiana are trademarks of BrokerTec Europe LTD, EBS Group LTD, TriOptima AB, and Traiana, Inc., respectively. Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc.  All other trademarks are the property of their respective owners. 

CME-G

 

Cision View original content:http://www.prnewswire.com/news-releases/cme-group-fx-futures-reach-new-volume-and-open-interest-records-300974542.html

SOURCE CME Group

In This Story

CME